NASDAQ: CYTK
Cytokinetics Inc Stock Ownership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Sandford D. SmithDirector2022-01-03122$46.00
$5.61kBuy
Edward M. MD KayeDirector2022-01-03244$46.00
$11.22kBuy
John T. HendersonDirector2022-01-03244$46.00
$11.22kBuy
Robert CaliffDirector2022-01-03122$46.00
$5.61kBuy
Muna BhanjiDirector2022-01-03244$46.00
$11.22kBuy
Nancy WysenskiDirector2022-01-03122$46.00
$5.61kBuy
Wendall WierengaDirector2022-01-03122$46.00
$5.61kBuy
Sandford D. SmithDirector2021-12-274,166$24.32
$101.32kBuy
Sandford D. SmithDirector2021-12-274,124$15.43
$63.63kBuy
Wendall WierengaDirector2021-12-274,166$5.46
$22.75kBuy

1 of 21

CYTK insiders have sold more... subscribe to Premium to read more.
Ownership

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.81%13,262,947$417.38MInstitution
Fmr LLC14.88%12,485,007$392.90MInstitution
Michael Schmertzler11.60%9,730,131$306.21MInsider
Vanguard Group Inc6.34%5,314,531$167.25MInstitution
State Street Corp5.14%4,310,288$135.64MInstitution
Pfm Health Sciences LP3.77%3,159,701$99.44MInstitution
Polar Capital Holdings PLC3.59%3,014,882$94.88MInstitution
Driehaus Capital Management LLC3.44%2,889,526$90.93MInstitution
Capital Ltd Eastern3.44%2,883,845$90.75MInsider
Farallon Capital Management LLC3.26%2,732,775$86.00MInstitution

1 of 3

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 107.60% institutional shareholders, 17.52% Cytokinetics insiders, and 0.00% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 11.60% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $296.57M.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.